INTERNATIONAL JOURNAL OF HYPERTHERMIA
Scope & Guideline
Elevating cancer treatment with groundbreaking hyperthermia studies.
Introduction
Aims and Scopes
- Thermal Ablation Techniques:
The journal extensively covers various thermal ablation methods like high-intensity focused ultrasound (HIFU), microwave ablation, and radiofrequency ablation, detailing their efficacy in treating different types of tumors. - Clinical Applications and Outcomes:
A significant focus on clinical outcomes related to hyperthermia, including studies on patient safety, treatment efficacy, and long-term follow-up results in various cancers, particularly hepatocellular carcinoma and thyroid cancers. - Technological Innovations:
Research on novel technologies and methodologies for enhancing hyperthermia treatments, including imaging techniques for guidance and monitoring, as well as the development of new devices and protocols. - Mechanistic Studies:
Investigations into the biological mechanisms underlying the effects of hyperthermia and thermal treatments, including cellular responses, immune responses, and molecular pathways. - Combination Therapies:
Exploration of the synergistic effects of combining hyperthermia with other treatment modalities such as chemotherapy, radiotherapy, and immunotherapy to improve patient outcomes.
Trending and Emerging
- Personalized Medicine Approaches:
An increasing trend towards personalized treatment strategies in hyperthermia, incorporating patient-specific factors and genetic profiles to optimize therapeutic outcomes. - Integration of Imaging Techniques:
Emerging emphasis on utilizing advanced imaging techniques, such as MRI and ultrasound, for accurate monitoring and guidance during hyperthermia treatments, enhancing precision and safety. - Immunotherapy Synergies:
A growing body of research exploring the combination of hyperthermia with immunotherapeutic agents, highlighting the potential to enhance immune responses against tumors. - Novel Drug Delivery Systems:
Investigations into innovative drug delivery systems in conjunction with hyperthermia, such as thermosensitive liposomes or nanoparticles, to improve therapeutic efficacy. - Real-Time Monitoring Technologies:
Increased focus on the development of real-time monitoring technologies for thermal therapies, allowing for dynamic adjustments during treatment to enhance effectiveness and minimize damage to surrounding tissues.
Declining or Waning
- Non-Oncological Applications:
Research related to non-oncological applications of hyperthermia, such as in rheumatic diseases or other non-cancerous conditions, has been less prominent compared to the emphasis on oncological treatments. - Basic Science Studies:
There is a noticeable decrease in basic science studies focused on thermal physics or biophysics of hyperthermia, as the journal has shifted towards clinical and translational research. - Longitudinal Studies on Thermal Effects:
Long-term studies assessing the chronic effects of hyperthermia or thermal damage on tissues have become less frequent, possibly due to a shift towards immediate clinical outcomes. - Historical Reviews and Meta-Analyses:
The publication of broad historical reviews or comprehensive meta-analyses on previously established techniques is declining, as the journal prioritizes innovative and novel research findings.
Similar Journals
Circulation-Arrhythmia and Electrophysiology
Leading the charge in electrophysiological advancements.Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
Pioneering Research in Cardiac ElectrophysiologyJOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, published by Wiley, stands at the forefront of the fields of Cardiology and Cardiovascular Medicine, boasting an impressive Impact Factor that reflects its scholarly influence. With a strong focus on innovative research, this esteemed journal has been a vital resource for advancing our understanding of electrophysiological concepts since its inception in 1990. As a Q1 journal in both Cardiology and Physiology (medical) as of 2023, it provides a platform for cutting-edge discoveries and comprehensive reviews that cater to the academic and clinical needs of researchers, practitioners, and students alike. The journal features rigorous peer-reviewed articles that delve into various aspects of cardiovascular health, enhancing both theoretical knowledge and clinical application. Although it does not offer open access, it remains a key resource for those engaged in cardiovascular research, published quarterly through 2024 to ensure timely dissemination of high-quality findings.
Hepatic Oncology
Exploring New Horizons in Liver Cancer TreatmentHepatic Oncology is a premier Open Access journal published by Future Medicine Ltd that specializes in the critical intersection of hepatology and oncology. With a focus on advancing knowledge in the diagnosis and treatment of liver cancers, the journal provides a platform for innovative research, reviews, and clinical perspectives that serve as a valuable resource for researchers, clinicians, and students alike. Established in 2016 and evolving over the years, Hepatic Oncology underscores its commitment to accessible scientific communication, having transitioned to open access in 2018 to reach a broader audience. The journal holds a Q4 quartile ranking in the fields of hepatology and oncology for 2023, reflecting its emerging influence and role in contemporary research. Through high-quality articles and a focus on real-world applications, Hepatic Oncology aims to bridge gaps in knowledge while fostering collaboration among professionals dedicated to enhancing patient care in hepatic malignancies.
Radiology and Oncology
Leading the way in diagnostic imaging and cancer research.Radiology and Oncology is a prominent open access journal that has been instrumental in advancing the fields of radiology and oncology since its inception in 1992. Published by SCIENDO in Germany, this journal aims to disseminate high-quality research articles, reviews, and case studies that address critical issues in diagnostic imaging and cancer treatment. As of 2023, it holds a commendable impact factor within the Q2 category for Radiology, Nuclear Medicine, and Imaging, and a Q3 standing in the field of Oncology—reflecting its importance in these critical areas of medicine. With a focus on promoting innovative research and interdisciplinary collaboration, Radiology and Oncology is indexed in Scopus, where it ranks #122 among 333 in its category and #187 among 404 in Oncology, showcasing its wide-reaching impact and relevance. The journal is fully open access since 2007, ensuring that vital research is accessible to the global medical community and fostering advancements in patient care strategies and therapeutic methodologies. By providing a platform for the latest developments and discoveries, Radiology and Oncology is a pivotal resource for researchers, clinicians, and students dedicated to improving outcomes in cancer care through innovative imaging techniques.
Blood Cancer Discovery
Driving Collaborative Efforts for Better Patient OutcomesBlood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.
Indian Journal of Gynecologic Oncology
Connecting the dots between research and clinical excellence.Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.
JACC-Clinical Electrophysiology
Connecting Researchers and Clinicians in ElectrophysiologyJACC-Clinical Electrophysiology, published by Elsevier, stands as a leading journal in the fields of Cardiology and Physiology, with an esteemed Q1 ranking in both categories as of 2023. With an ISSN of 2405-500X and E-ISSN 2405-5018, this journal serves as an essential platform for disseminating cutting-edge research, clinical studies, and innovative practices related to electrophysiological aspects of cardiovascular health. Established in 2015, JACC-Clinical Electrophysiology has attracted high-quality submissions, reflected in its strong presence on Scopus, ranking 41st out of 387 in Cardiology and 15th out of 113 in Physiology (medical), placing it in the 89th and 87th percentiles respectively. Though it operates on a subscription model, its commitment to high standards of peer-reviewed scholarship makes it an indispensable resource for researchers, clinicians, and students dedicated to advancing knowledge and practice in electrophysiology and its impact on cardiac care. Join the community of leaders in the field by engaging with the latest findings and discussions published in this prestigious journal.
Iranian Journal of Radiology
Unveiling Insights in Radiology and Medical ImagingWelcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.
Thyroid Research
Unlocking insights into thyroid function.Thyroid Research is a pioneering open-access journal published by BMC, dedicated to advancing knowledge in the field of thyroid function and its implications in human health. Since its inception in 2008, this journal has facilitated the dissemination of critical research findings, making vital contributions to the fields of Endocrinology, Diabetes, and Metabolism. With its editorial focus encompassing a wide range of topics related to thyroid disorders, treatments, and molecular mechanisms, Thyroid Research serves as a vital resource for researchers, clinicians, and students alike. Ranking in the Q3 category for Endocrinology and related disciplines, the journal offers valuable insights and fosters collaborative discussions among experts worldwide. Its Open Access model ensures that cutting-edge research is readily available to all, promoting greater understanding and innovative practices in both clinical and laboratory settings. Researchers from diverse backgrounds are encouraged to explore the journal's rich archives and contribute to this growing body of knowledge.
PHLEBOLOGY
Advancing venous health through rigorous research.PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.